MSK cellular therapist Dr. Heather Landau led a phase 1 clinical trial showing CAR T cell therapy is effective against relapsed or resistant AL amyloidosis. “I’ve seen very sick patients have an ...

A clinical trial at MSK found that music therapy for cancer-related anxiety is as effective as cognitive behavioral therapy and produces long-lasting benefits. Dr. Kevin Liou presented the results of ...

A research team is shedding new light on Bacillus Calmette-Guerin (BCG), a decades-old bladder cancer treatment, which is also given as vaccine against tuberculosis. The findings could help improve ...

A new study leveraged data from the MSK-IMPACT tumor sequencing test to learn about the genetic complexity of cancer metastasis. When cancer spreads from a primary tumor to new sites throughout the ...

Beatriz Sawaya came to MSK from Brazil to receive a new treatment for resistant breast cancer as part of a clinical trial. The therapy has kept her cancer under control for more than five years and ...

We treat every type of cancer, including the most important one: yours. With cancer, where you get treated first matters. From diagnosis to treatment, our experts provide the care and support you need ...

Research at MSK Our research impact Research topics Core facilities & resources ...

A decade ago, a clinical trial in the U.K. famously showed that children who were exposed to peanuts in the early months of life had reduced risk of developing a peanut allergy compared with children ...

Ready to start planning your care? Call us at 800-525-2225 to make an appointment.

Find a researcher or lab Education & training programs MSK Innovation MSK Commercialization Ecosystem ...

As long-term cancer survival outcomes improve, the brain has increasingly become a site of refractory and recurrent disease. At Memorial Sloan Kettering Cancer Center (MSK), neurosurgeon Nelson Moss, ...